Analyst firms · H.C. Wainwright · IVA

H.C. Wainwright IVA price target and rating history

Inventiva S.A. (IVA) · Health Care

H.C. Wainwright rates Inventiva S.A. (IVA) Buy with a $20 price target, as of its latest action on Sep 3, 2025. It has published 3 rating actions on IVA since September 2021, including 0 upgrades and 0 downgrades. Across 4 firms with a IVA price target in the last 12 months, the median target is $12.50.

Current rating
Buy
Price target
$20
Median target, all firms
$12.50
Actions on IVA
3

H.C. Wainwright price target on IVA

$42$31$2020222023202420252026
H.C. Wainwright price target on IVA, each point a stated target, September 2021 to September 2025.

Every H.C. Wainwright rating on IVA

How other firms rate IVA

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Cantor FitzgeraldOverweightJul 17, 2026
Truist SecuritiesBuy$13Mar 19, 2026
BarclaysOverweight$18Jan 28, 2026
Leerink PartnersOutperform$12Jan 12, 2026
UBSBuy$12Jan 7, 2026

Questions about H.C. Wainwright and IVA

What is H.C. Wainwright's price target for IVA?
H.C. Wainwright's latest stated price target for Inventiva S.A. (IVA) is $20, from its action on Sep 3, 2025.
What is H.C. Wainwright's rating on IVA?
H.C. Wainwright rates IVA Buy, a bullish rating, as of Sep 3, 2025.
When did H.C. Wainwright last change its view on IVA?
On Sep 3, 2025, H.C. Wainwright resumes coverage at Buy, price target $20.
How does H.C. Wainwright's IVA target compare with other analysts?
Across 4 firms with a IVA price target in the last 12 months, the median target is $12.50.

All H.C. Wainwright ratingsIVA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.